Red Biotechnology Market Size, Share & Trends Report

Red Biotechnology Market Size, Share & Trends Analysis Report By Product, By End-user (Academic Research Institutes, CMOs & CROs, Pharmaceutical & Biotechnology Companies, Others), By Region, And Segment Forecasts, 2023 - 2030

Report ID: GVR-4-68040-042-9
Number of Pages: 180
Format: Electronic (PDF)

Historical Range: 2018 - 2021
Industry:Healthcare

Market Segmentation

Red Biotechnology Product Scope Outlook (Revenue, USD Billion, 2018 - 2030)
- Monoclonal Antibodies
- Polyclonal Antibodies
- Recombinant Proteins
- Vaccines
- Cell-Based Immunotherapy Products
- Gene Therapy Products
- Cell Therapy Products
- Tissue-Engineered Products
- Stem Cells
- cell culture
- Viral Vector
- Enzymes
- Kits and Reagents
- Animal models
- Molecular diagnostics
- Others
Red Biotechnology End-user Scope Outlook (Revenue, USD Billion, 2018 - 2030)
- Academic Research Institutes
- CMOs & CROs
- Pharmaceutical & Biotechnology Companies
- Others
Red Biotechnology Regional Outlook (Revenue, USD Billion, 2018 - 2030)
- North America
  - North America red biotechnology market, By Product, 2018 - 2030 (USD Billion)
    - Monoclonal Antibodies
    - Polyclonal Antibodies
    - Recombinant Proteins
    - Vaccines
    - Cell-Based Immunotherapy Products
    - Gene Therapy Products
    - Cell Therapy Products
    - Tissue-Engineered Products
    - Stem Cells
    - Cell culture
    - Viral Vector
    - Enzymes
    - Kits and Reagents
    - Animal models
    - Molecular diagnostics
    - Others
  - North America red biotechnology market, By End-user, 2018 - 2030 (USD Billion)
    - Academic Research Institutes
    - CMOs & CROs
    - Pharmaceutical & Biotechnology Companies
    - Others
  - U.S.
    - U.S. red biotechnology market, By Product, 2018 - 2030 (USD Billion)
      - Monoclonal Antibodies
      - Polyclonal Antibodies
      - Recombinant Proteins
      - Vaccines
      - Cell-Based Immunotherapy Products
      - Gene Therapy Products
      - Cell Therapy Products
      - Tissue-Engineered Products
      - Stem Cells
      - Cell culture
      - Viral Vector
      - Enzymes
      - Kits and Reagents
      - Animal models
      - Molecular diagnostics
      - Others
    - U.S. red biotechnology market, By End-user, 2018 - 2030 (USD Billion)
      - Academic Research Institutes
      - CMOs & CROs
      - Pharmaceutical & Biotechnology Companies
      - Others
  - Canada
    - Canada red biotechnology market, By Product, 2018 - 2030 (USD Billion)
      - Monoclonal Antibodies
      - Polyclonal Antibodies
      - Recombinant Proteins
      - Vaccines
      - Cell-Based Immunotherapy Products
      - Gene Therapy Products
      - Cell Therapy Products
      - Tissue-Engineered Products
      - Stem Cells
      - Cell culture
      - Viral Vector
      - Enzymes
      - Kits and Reagents
      - Animal models
      - Molecular diagnostics
      - Others
    - Canada red biotechnology market, By End-user, 2018 - 2030 (USD Billion)
      - Academic Research Institutes
      - CMOs & CROs
      - Pharmaceutical & Biotechnology Companies
      - Others
- Europe
- Asia Pacific
  - Asia Pacific red biotechnology market, By Product, 2018 - 2030 (USD Billion)
    - Monoclonal Antibodies
    - Polyclonal Antibodies
    - Recombinant Proteins
    - Vaccines
    - Cell-Based Immunotherapy Products
    - Gene Therapy Products
    - Cell Therapy Products
    - Tissue-Engineered Products
    - Stem Cells
    - Cell culture
    - Viral Vector
    - Enzymes
    - Kits and Reagents
    - Animal models
    - Molecular diagnostics
    - Others
  - Asia Pacific red biotechnology market, By End-user, 2018 - 2030 (USD Billion)
    - Academic Research Institutes
    - CMOs & CROs
    - Pharmaceutical & Biotechnology Companies
    - Others
  - Japan
    - Japan red biotechnology market, By Product, 2018 - 2030 (USD Billion)
      - Monoclonal Antibodies
      - Polyclonal Antibodies
      - Recombinant Proteins
      - Vaccines
      - Cell-Based Immunotherapy Products
      - Gene Therapy Products
      - Cell Therapy Products
      - Tissue-Engineered Products
      - Stem Cells
      - Cell culture
      - Viral Vector
      - Enzymes
      - Kits and Reagents
      - Animal models
      - Molecular diagnostics
      - Others
    - Japan red biotechnology market, By End-user, 2018 - 2030 (USD Billion)
      - Academic Research Institutes
      - CMOs & CROs
      - Pharmaceutical & Biotechnology Companies
      - Others
  - China
    - China red biotechnology market, By Product, 2018 - 2030 (USD Billion)
      - Monoclonal Antibodies
      - Polyclonal Antibodies
      - Recombinant Proteins
      - Vaccines
      - Cell-Based Immunotherapy Products
      - Gene Therapy Products
      - Cell Therapy Products
      - Tissue-Engineered Products
      - Stem Cells
      - Cell culture
      - Viral Vector
      - Enzymes
      - Kits and Reagents
      - Animal models
      - Molecular diagnostics
      - Others
    - China red biotechnology market, By End-user, 2018 - 2030 (USD Billion)
      - Academic Research Institutes
      - CMOs & CROs
      - Pharmaceutical & Biotechnology Companies
      - Others
  - India
    - India red biotechnology market, By Product, 2018 - 2030 (USD Billion)
      - Monoclonal Antibodies
      - Polyclonal Antibodies
      - Recombinant Proteins
      - Vaccines
      - Cell-Based Immunotherapy Products
      - Gene Therapy Products
      - Cell Therapy Products
      - Tissue-Engineered Products
      - Stem Cells
      - Cell culture
      - Viral Vector
      - Enzymes
      - Kits and Reagents
      - Animal models
      - Molecular diagnostics
      - Others
    - India red biotechnology market, By End-user, 2018 - 2030 (USD Billion)
      - Academic Research Institutes
      - CMOs & CROs
      - Pharmaceutical & Biotechnology Companies
      - Others
  - South Korea
    - South Korea red biotechnology market, By Product, 2018 - 2030 (USD Billion)
      - Monoclonal Antibodies
      - Polyclonal Antibodies
      - Recombinant Proteins
      - Vaccines
      - Cell-Based Immunotherapy Products
      - Gene Therapy Products
      - Cell Therapy Products
      - Tissue-Engineered Products
      - Stem Cells
      - Cell culture
      - Viral Vector
      - Enzymes
      - Kits and Reagents
      - Animal models
      - Molecular diagnostics
      - Others
    - South Korea red biotechnology market, By End-user, 2018 - 2030 (USD Billion)
      - Academic Research Institutes
      - CMOs & CROs
      - Pharmaceutical & Biotechnology Companies
      - Others
  - Australia
    - Australia red biotechnology market, By Product, 2018 - 2030 (USD Billion)
      - Monoclonal Antibodies
      - Polyclonal Antibodies
      - Recombinant Proteins
      - Vaccines
      - Cell-Based Immunotherapy Products
      - Gene Therapy Products
      - Cell Therapy Products
      - Tissue-Engineered Products
      - Stem Cells
      - Cell culture
      - Viral Vector
      - Enzymes
      - Kits and Reagents
      - Animal models
      - Molecular diagnostics
      - Others
    - Australia red biotechnology market, By End-user, 2018 - 2030 (USD Billion)
      - Academic Research Institutes
      - CMOs & CROs
      - Pharmaceutical & Biotechnology Companies
      - Others
  - Thailand
    - Thailand red biotechnology market, By Product, 2018 - 2030 (USD Billion)
      - Monoclonal Antibodies
      - Polyclonal Antibodies
      - Recombinant Proteins
      - Vaccines
      - Cell-Based Immunotherapy Products
      - Gene Therapy Products
      - Cell Therapy Products
      - Tissue-Engineered Products
      - Stem Cells
      - Cell culture
      - Viral Vector
      - Enzymes
      - Kits and Reagents
      - Animal models
      - Molecular diagnostics
      - Others
    - 泰国红生物技术市场,终端用户,2018 - 2030 (USD Billion)
      - Academic Research Institutes
      - CMOs & CROs
      - Pharmaceutical & Biotechnology Companies
      - Others
- Latin America
- Middle East & Africa
  - Middle East & Africa red biotechnology market, By Product, 2018 - 2030 (USD Billion)
    - Monoclonal Antibodies
    - Polyclonal Antibodies
    - Recombinant Proteins
    - Vaccines
    - Cell-Based Immunotherapy Products
    - Gene Therapy Products
    - Cell Therapy Products
    - Tissue-Engineered Products
    - Stem Cells
    - Cell culture
    - Viral Vector
    - Enzymes
    - Kits and Reagents
    - Animal models
    - Molecular diagnostics
    - Others
  - Middle East & Africa red biotechnology market, By End-user, 2018 - 2030 (USD Billion)
    - Academic Research Institutes
    - CMOs & CROs
    - Pharmaceutical & Biotechnology Companies
    - Others
  - South Africa
    - South Africa red biotechnology market, By Product, 2018 - 2030 (USD Billion)
      - Monoclonal Antibodies
      - Polyclonal Antibodies
      - Recombinant Proteins
      - Vaccines
      - Cell-Based Immunotherapy Products
      - Gene Therapy Products
      - Cell Therapy Products
      - Tissue-Engineered Products
      - Stem Cells
      - Cell culture
      - Viral Vector
      - Enzymes
      - Kits and Reagents
      - Animal models
      - Molecular diagnostics
      - Others
    - South Africa red biotechnology market, By End-user, 2018 - 2030 (USD Billion)
      - Academic Research Institutes
      - CMOs & CROs
      - Pharmaceutical & Biotechnology Companies
      - Others
  - Saudi Arabia
    - Saudi Arabia red biotechnology market, By Product, 2018 - 2030 (USD Billion)
      - Monoclonal Antibodies
      - Polyclonal Antibodies
      - Recombinant Proteins
      - Vaccines
      - Cell-Based Immunotherapy Products
      - Gene Therapy Products
      - Cell Therapy Products
      - Tissue-Engineered Products
      - Stem Cells
      - Cell culture
      - Viral Vector
      - Enzymes
      - Kits and Reagents
      - Animal models
      - Molecular diagnostics
      - Others
    - Saudi Arabia red biotechnology market, By End-user, 2018 - 2030 (USD Billion)
      - Academic Research Institutes
      - CMOs & CROs
      - Pharmaceutical & Biotechnology Companies
      - Others
  - UAE
    - UAE red biotechnology market, By Product, 2018 - 2030 (USD Billion)
      - Monoclonal Antibodies
      - Polyclonal Antibodies
      - Recombinant Proteins
      - Vaccines
      - Cell-Based Immunotherapy Products
      - Gene Therapy Products
      - Cell Therapy Products
      - Tissue-Engineered Products
      - Stem Cells
      - Cell culture
      - Viral Vector
      - Enzymes
      - Kits and Reagents
      - Animal models
      - Molecular diagnostics
      - Others
    - UAE red biotechnology market, By End-user, 2018 - 2030 (USD Billion)
      - Academic Research Institutes
      - CMOs & CROs
      - Pharmaceutical & Biotechnology Companies
      - Others
  - Kuwait
    - Kuwait red biotechnology market, By Product, 2018 - 2030 (USD Billion)
      - Monoclonal Antibodies
      - Polyclonal Antibodies
      - Recombinant Proteins
      - Vaccines
      - Cell-Based Immunotherapy Products
      - Gene Therapy Products
      - Cell Therapy Products
      - Tissue-Engineered Products
      - Stem Cells
      - Cell culture
      - Viral Vector
      - Enzymes
      - Kits and Reagents
      - Animal models
      - Molecular diagnostics
      - Others
    - Kuwait red biotechnology market, By End-user, 2018 - 2030 (USD Billion)
      - Academic Research Institutes
      - CMOs & CROs
      - Pharmaceutical & Biotechnology Companies
      - Others

Report content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
乐鱼体育手机网站入口
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments

Quantitative Analysis

Market size, estimates, and forecast from 2018 to 2030
Market estimates and forecast for product segments up to 2030
Regional market size and forecast for product segments up to 2030
Market estimates and forecast for application segments up to 2030
Regional market size and forecast for application segments up to 2030
Company financial performance

GET A FREE SAMPLE

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

Or view our licence options:

NEED A CUSTOM REPORT?

We can customize every report -free of charge- including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

ESOMAR certified & member

Leading SME award by D&B

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read ourprivacy policy.